The Healthcare Business Model Canvas
A structured framework for building and testing business models in complex, multi-sided healthcare markets.
John Collins · jcollins11@mgh.harvard.edu
The Problem
Healthcare is structurally unlike most other industries. The person who uses a solution is rarely the person who pays for it. The people who decide whether it can be sold or reimbursed is different again. Regulatory bodies, payors, specialty boards, and key opinion leaders all shape adoption. A business model framework that does not account for this complexity will not produce viable commercial strategies.
The H-BMC
The Healthcare Business Model Canvas (H-BMC) is a structured framework that adapts Osterwalder's Business Model Canvas specifically for healthcare innovation. It organizes the key assumptions behind a healthcare business model into 12 testable hypothesis blocks and three financial calculation blocks — 15 blocks in total across five tiers. — making them explicit, testable, and actionable.
The H-BMC addresses both HealthTech solutions — medical devices, diagnostics, and combination products — and Digital Medicine solutions — software as a medical device, AI diagnostics, remote monitoring, and digital therapeutics. Where these two categories have meaningfully different commercial dynamics, the framework addresses them separately.
The Framework
The Five Tiers
The H-BMC organizes 15 blocks across five tiers, each covering a distinct layer of the business model.
| Tier | Layer | Blocks | Why It Matters |
|---|---|---|---|
|
Value Foundation
|
Value Foundation | 1. Value Promise The core unmet need, why it matters, and why your solution is the right answer. |
The anchor of the entire canvas. Every other block must support and validate it. |
|
Stakeholder
|
Primary Stakeholders | 2. Users · 3. Economic Buyers Who uses the solution and who pays for it — almost never the same person in healthcare. |
Defines the critical distinction between clinical users and institutional buyers that the standard BMC misses. |
| Adoption Influencers | 4. Expert Influencers · 5. Authorities Clinical champions, KOLs, anti-buyers, regulators, payors, specialty boards. |
Maps the individuals and institutions that shape adoption without ever transacting with the company. | |
|
Economic Model
|
Economic Model | 6. Value Quantification · 7. Market Size · 8. Transaction Model The economic case for buyers, volume of potential use, and how each use converts to revenue. |
Translates clinical value into institutional economics and a credible revenue model. |
|
Operations
|
External Relationships | 9. Channels and Customer Relationships · 10. Key Partners How you reach stakeholders and what external relationships make delivery possible. |
Defines how the model reaches the market and what strategic partnerships sustain it. |
| Core Operations | 11. Key Activities · 12. Key Resources What you must do in-house and what assets make the model defensible. |
The internal foundation required to execute reliably and compete effectively. | |
|
Financial
|
Financial Model | 13. Cost Structure · 14. Revenue Stream What it costs to operate the model and what revenue it generates at scale. |
Shows whether the model is sustainable and capable of generating profit. |
| Investment Case | 15. Investor Economics Gross margin, unit economics, capital requirements, and return potential. |
Synthesizes the model into the metrics investors and program funders use to evaluate fundability. |
What Makes It Different
Four structural changes from the standard BMC make the H-BMC suited to healthcare:
Users and Economic Buyers are separated
In healthcare, the clinician who uses a solution and the institution that buys it are almost always different people with different priorities. The H-BMC addresses both explicitly with separate blocks and separate value cases.
Influencers are a distinct category
Clinical champions, KOLs, anti-buyers, regulators, payors, and specialty boards all shape adoption without transacting with the company. The H-BMC maps these relationships and their impact on commercial strategy.
Value is quantified for institutional buyers
Beyond the clinical value promise to users, the H-BMC requires teams to build a rigorous economic case for institutional buyers — connecting clinical outcomes to cost savings, revenue enhancement, and operational efficiency.
The financial model is grounded in testable hypotheses
Market size, transaction model, cost structure, and investor economics are all derived from upstream assumptions that can be tested and refined as evidence accumulates — not projected from top-down market reports.
Designed for Programs
The H-BMC was developed through years of work with healthcare innovation programs including CRAASH, NIH I-Corps, NSF I-Corps, C3i, and Blueprint Medtech. It is designed to be used in structured innovation programs where teams need a common framework for building, testing, and communicating their business models to mentors, program directors, and funders.
Each block is documented with detailed guidance, worked examples, and — where HealthTech and Digital Medicine have different commercial dynamics — category-specific content. The framework is hosted on the GAITS platform and integrates directly with the GAITS-AI suite of tools that support structured stakeholder discovery, business model development, and funding readiness assessment.
The complete H-BMC Framework Guide — including full descriptions of all 15 blocks, worked examples, hypothesis forming methodology, and market definition frameworks — is available to GAITS team members.
If you are a GAITS team member, log in and access the full guide at gaits.org/hbmc.
Interested in adopting the H-BMC for your program? Contact John Collins at jcollins11@mgh.harvard.edu.